Aziyo Biologics, Inc. (AZYO) Tops Q4 EPS by 25c

Aziyo Biologics, Inc. (NASDAQ: AZYO) reported Q4 EPS of ($0.38), $0.25 better than the analyst estimate of ($0.63). Revenue for the quarter came in at $12.7 million versus the consensus estimate of $12.48 million.

For earnings history and earnings-related data on Aziyo Biologics, Inc. (AZYO) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Calamp Corp. (CAMP) Misses Q2 EPS by 33c